Finally, we found that if patients with TMPRSS2:ERG fusion positive prostate cancer were smokers, they had significantly higher number of biopsy cores positive for cancer, and each core contained a larger proportion of tumor tissue, compared to TMPRSS2:ERG negative smokers, suggesting an increased tumor volume in these patients. This evidence concerns the gene TMPRSS2 and neoplasm.